IRIS
Stefania, Chiappini
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 130
NA - Nord America 1
Totale 131
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 130
US - Stati Uniti d'America 1
Totale 131
Salva come PNG Salva come JPEG
Città #
Rome 130
Santa Clara 1
Totale 131
Salva come PNG Salva come JPEG
Nome #
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): An Analysis of Pharmacovigilance Databases 5
An Update on Psychoactive Substances: Pharmacology and Toxicology Issues 4
'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports 4
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 4
An insight into Z-drugs abuse and dependence: an examination of reports to the European Medicines Agency (EMA) database of suspected Adverse Drug Reactions (ADR) 3
Knowledge and use of over-the-counter drugs in Italy: an exploratory survey-based study in the general population 3
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 3
A decade of gabapentinoid misuse: an analysis of the European Medicines Agency's ‘suspected adverse drug reactions' database. Assessment of gabapentinoid misuse/dependence as reported to the EMA 3
Beyond the purple drank. Study of promethazine abuse according to the Eurovigilance dataset 3
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 3
Psychobiological, medical, and psychiatric implications of new/novel psychoactive substance (NPS) use 3
Pregabalin treatment in pathological gambling: a preliminary study 3
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 2
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review 2
Pregabalin: a range of misuse-related unanswered questions 2
A multidisciplinary approach for addiction treatment in an Italian day hospital service: a therapy model and its goals 2
Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review and Meta-analysis of side effects 2
Assessing The 2004-2018 Fentanyl Misusing Issues Reported To An International Range Of Adverse Reporting Systems 2
Alprazolam-related deaths in Scotland, 2004-2020 2
2876 – Glutamatergic strategies in the treatment of pathological gambling: a pilot study 2
Pharmacovigilance signals of the opioid epidemic over 10 years: an analysis of pharmacovigilance datasets collecting Adverse Drug Reactions (ADRs) reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS) 2
Addiction: a therapeutic model for the restructuring of identity 2
NPS stimulants 2
Beyond the ‘purple drank’. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports 2
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 2
Behavioural Addictions In Adolescence: Findings From An Italian Survey 2
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 2
ARE Z-DRUGS SAFE? STUDY OF THEIR MISUSE, ABUSE AND DEPENDENCE ACCORDING TO THE EUROPEAN MEDICINES AGENCY (EMA) PHARMACOVIGILANCE DATABASE. 2
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 2
Relationship between impulsivity, mood disorders and personality traits in a sample of pathological gamblers 2
Substance-Use Disorders and Violence 2
Age in Pathological Gambling: Correlations with Personality and Psychiatric Comorbidity. 2
Le nuove sostanze psicoattive 2
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 1
Methoxetamine: An Analogue of Ketamine 1
Evaluation of an italian sample of gamblers with dannon ainhold gambling scale: preliminary study 1
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database 1
The bridge between classical and ‘synthetic'/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective 1
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 1
Cannabis: evidenze epidemiologiche, cliniche e terapeutiche 1
The e-psychonaut drugs' psychopharmacology 1
The Unregulated Psychoactive Compound: ‘Benzo Fury' 1
Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports 1
Cannabidiol (CBD) Use in Psychiatric Disorders: a Systematic Review 1
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 1
Misuse of Anticholinergic Medications: A Systematic Review 1
The misuse of prescription drugs in the digital era: pros and cons 1
Opioid painkiller dependence in a sample of elderly medical inpatients 1
Compulsiveness dimension in a case of pathological gambling 1
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 1
Gestione dei pazienti con depressione resistente al trattamento in comorbilità con il disturbo da uso di sostanze: sicurezza ed efficacia dell'esketamina in un sottocampione di pazienti dello studio REAL-ESK 1
The benzydamine experience: a systematic review of benzydamine abuse 1
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 1
Brexpiprazole as a new approach of treatment in somatization disorder 1
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 1
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel 1
Nuove frontiere nell'abuso di sostanze, psiconauti e internet 1
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 1
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 1
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 1
Misuse and Abuse of Prescription Drugs in Custodial Settings 1
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 1
Evaluating craving in Alcohol Use Disorder: psychometric characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 1
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 1
Efficacy of psychosocial and psychological interventions in addition to drug therapy to improve global functioning of inpatients with schizophrenia spectrum and mood disorders: a real-world observational study 1
Climate change, biodiversity loss and mental health: a global perspective 1
The opioid epidemic over the past 10 years: pharmacovigilance signals from the European Medicines Agency (EMA) and the FDA Adverse Event Reporting System (FAERS) 1
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 1
Behavioural changes in cocaine dependent patients after group-therapy 1
The role of novel psychoactive substances (NPS) in mental health care of young people: a systematic review 1
Is there a potential of misuse for quetiapine? Literature review and analysis of the European Medicines Agency/EMA Adverse Drug Reactions' database 1
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 1
Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years 1
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 1
There is a potential of misuse for venlafaxine and bupropion? 1
Online Gambling, Impulsivity and Personality Traits: an Italian Sample 1
COVID-19: The hidden impact on mental health and drug addiction 1
Psychosocial risk factors for postpartum depression: a descriptive sample of pregnants 1
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 1
New psychoactive substances and suicidality: A systematic review of the current literature 1
Loperamide diversion and abuse: assessment of its non-medical use through the analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 1
Totale 131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025130 21 102 3 0 4 0 0 0 0 0 0 0
Totale 131